N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works

Antioxidant activity applying an improved ABTS radical cation decolorization assay

Re, R., Pellegrini, N., Proteggente, A. R., Pannala, A. S., Yang, M. H., & Rice-Evans, C. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00315-3 · Cited by 26,298 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484 · see citing works

Global prevalence of dementia: a Delphi consensus study

Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336 · see citing works

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · see citing works

Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)

Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729 · see citing works

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · see citing works

The metallobiology of Alzheimer's disease

Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315 · see citing works

High throughput artificial membrane permeability assay for blood–brain barrier

Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195 · see citing works

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction

Huang, X., Atwood, C., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J. T., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107 · see citing works

Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis

Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · see citing works

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · see citing works

Intramuscular desferrioxamine in patients with Alzheimer's disease

MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764 · see citing works

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725 · see citing works

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672 · see citing works

Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid

Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 580 · see citing works

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration

Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980402t · Cited by 523 · see citing works

Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion

Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482 · see citing works

Carbohydrates as ligands: coordination equilibria and structure of the metal complexes

Gyurcsik, B., & Nagy, L. (2000) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00183-6 · Cited by 428 · see citing works

Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids

Javitt, N. B. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.2.2153592 · Cited by 357 · see citing works

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332 · see citing works

Mechanism of Agrobacterium .beta.-glucosidase: kinetic studies

Kempton, J. B., & Withers, S. G. (1992) · Biochemistry · doi:10.1021/bi00156a015 · Cited by 276 · see citing works

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential

Dobbin, P. S., Hider, R. C., Hall, A. D., Taylor, P. D., Sarpong, P., Porter, J. B., Xiao, G., & der Helm, D. V. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a002 · Cited by 217 · see citing works

Design, Selection, and Characterization of Thioflavin-Based Intercalation Compounds with Metal Chelating Properties for Application in Alzheimer’s Disease

Rodríguez-Rodríguez, C., Sánchez de Groot, N., Rimola, A., Álvarez-Larena, Á., Lloveras, V., Vidal-Gancedo, J., Ventura, S., Vendrell, J., Sodupe, M., & González-Duarte, P. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806062g · Cited by 210 · see citing works

Small Molecule Modulators of Copper-Induced Aβ Aggregation

Hindo, S. S., Mancino, A. M., Braymer, J. J., Liu, Y., Vivekanandan, S., Ramamoorthy, A., & Lim, M. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907045h · Cited by 203 · see citing works

1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD

Kontoghiorghes, G., Sheppard, L. N., Aldouri, M. A., & Hoffbrand, A. V. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90545-9 · Cited by 177 · see citing works

Blood-brain barrier transport of caffeine: Dose-related restriction of adenine transport

McCall, A. L., Millington, W. R., & Wurtman, R. J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90715-9 · Cited by 158 · see citing works

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141 · see citing works

Enkephalin Glycopeptide Analogues Produce Analgesia with Reduced Dependence Liability

Bilsky, E. J., Egleton, R. D., Mitchell, S. A., Palian, M. M., Davis, P., Huber, J. D., Jones, H., Yamamura, H. I., Janders, J., Davis, T. P., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000077y · Cited by 133 · see citing works

Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents

Wu, W., Lei, P., Liu, Q. R., Hu, J., Gunn, A. P., Chen, M., Rui, Y., Su, X., Xie, Z., Zhao, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 124 · see citing works

In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind”

Goodwin, J. T., & Clark, D. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075705 · Cited by 113 · see citing works

Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation

Schugar, H. J., Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Böhmerle, K., Thomas, F. C., Allen, D. D., Lockman, P. R., Merkel, M., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603866 · Cited by 112 · see citing works

Differential Effects of Apolipoprotein E Isoforms on Metal-Induced Aggregation of Aβ Using Physiological Concentrations

Moir, R. D., Atwood, C., Romano, D., Laurans, M. H., Huang, X., Bush, A. I., Smith, J. D., & Tanzi, R. E. (1999) · Biochemistry · doi:10.1021/bi982437d · Cited by 111 · see citing works

Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone

Nurchi, V. M., Crisponi, G., Pivetta, T., Donatoni, M., & Remelli, M. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.10.012 · Cited by 106 · see citing works

Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level

Rodríguez‐Rodríguez, C., Rimola, A., Rodrı́guez-Santiago, L., Ugliengo, P., Álvarez‐Larena, Á., Gutiérrez‐de‐Terán, H., Sodupe, M., & Gonzalez-Duarte, P. (2010) · Chemical Communications · doi:10.1039/b912396b · Cited by 91 · see citing works

Operative Strategy for Pheochromocytomas Localized by [i-131]-M-Iodobenzylguanidine Scintigraphy

Thompson, N., & Gough, I. R. (1984) · The Lancet · Cited by 90 · see citing works

Synthesis, Physicochemical Properties, and Biological Evaluation of Hydroxypyranones and Hydroxypyridinones: Novel Bidentate Ligands for Cell-Labeling

Ellis, B. L., Duhme‐Klair, A., Hider, R. C., Hossain, M. B., RIZVI, S. K., & der Helm, D. V. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960220g · Cited by 88 · see citing works

Toxicity studies with ethyl maltol

Gralla, E. J. (1969) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(69)90062-3 · Cited by 78 · see citing works

Systemically administered d-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents

Battaglia, G., Russa, M. F. L., Bruno, V., Arenare, L., Ippolito, R., Copani, A., Bonina, F. P., & Nicoletti, F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01962-4 · Cited by 77 · see citing works

Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1Electronic supplementary information (ESI) available: experimental details for the preparation of all derivatives and biological assays. See http://www.rsc.org/suppdata/ob/b2/b212066f/

Fernández, C. I., Nieto, O., Fontenla, J. A., Rivas, E., CEBALLOS, M. L. D., & Fernández‐Mayoralas, A. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b212066f · Cited by 73 · see citing works

Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones

Zhang, Z., Rettig, S. J., & Orvig, C. (1991) · Inorganic Chemistry · doi:10.1021/ic00003a031 · Cited by 72 · see citing works

Thioflavin Derivatives as Markers for Amyloid‐β Fibrils: Insights into Structural Features Important for High‐Affinity Binding

Leuma Yona, R., Mazères, S., Faller, P., & Gras, E. (2008) · ChemMedChem · doi:10.1002/cmdc.200700188 · Cited by 72 · see citing works

Physical and structural studies of N-substituted-3-hydroxy-2-methyl-4(1H)-pyridinones

Nelson, W. O., Karpishin, T. B., Rettig, S. J., & Orvig, C. (1988) · Canadian Journal of Chemistry · doi:10.1139/v88-019 · Cited by 68 · see citing works

The effect of N-alkyl modification on the antimalarial activity of 3- hydroxypyridin-4-one oral iron chelators

Hershko, C., Theanacho, E., Spira, D. T., Peter, H., Dobbin, P. S., & Hider, R. C. (1991) · Blood · doi:10.1182/blood.v77.3.637.637 · Cited by 60 · see citing works

Crystal structure of the tris 1,2-dimethyl-3-hydroxy-4-pyridinone (DMHP) complex with the Fe(III) ion

Clarke, E. T., Martell, A. E., & Reibenspies, J. H. (1992) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)86121-6 · Cited by 58 · see citing works

Iron(III)-chelating resins. 3. Synthesis, iron(III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands

Feng, M. H., van der Does, L., & Bantjes, A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00071a013 · Cited by 43 · see citing works

Copper Complexation by 3-Hydroxypyridin-4-one Iron Chelators: Structural and Iron Competition Studies

Jammal, A. E., Howell, P. L., Turner, M. A., Li, N., & Templeton, D. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00030a005 · Cited by 43 · see citing works

Synthesis and X-ray crystal structure of tris(1,2-dimethyl-3-hydroxypyrid-4-onato)iron(III)

Charalambous, J., Dodd, A., McPartlin, M., Matondo, S. O. C., Pathirana, N. D., & Powell, H. R. (1988) · Polyhedron · doi:10.1016/s0277-5387(00)81813-6 · Cited by 40 · see citing works

Carbohydrate-Bearing 3-Hydroxy-4-pyridinonato Complexes of Gallium(III) and Indium(III)

Green, D. E., Ferreira, C. L., Stick, R. V., Patrick, B. O., Adam, M. J., & Orvig, C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501808 · Cited by 40 · see citing works

New analgesic and antiinflammatory agents 4(1H)-pyridinone derivatives

Öztürk, G., EROL, D. D., Aytemir, M. D., & Uzbay, T. I. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(02)01390-9 · Cited by 39 · see citing works

Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2008) · Dalton Transactions · doi:10.1039/b815404j · Cited by 38 · see citing works

?-Mimosine, an amino acid with maltol-type binding properties toward copper(II), oxovanadium(IV) and other metal ions

Chruscinska, E. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)80003-8 · Cited by 32 · see citing works

Physical and structural studies of N-carboxymethyl- and N-(p-methoxyphenyl)-3-hydroxy-2-methyl-4-pyridinone

Zhang, Z., Rettig, S. J., & Orvig, C. (1992) · Canadian Journal of Chemistry · doi:10.1139/v92-101 · Cited by 31 · see citing works

Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood−Brain Barrier

Roy, S., Preston, J. E., Hider, R. C., & Min, Y. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100380k · Cited by 20 · see citing works

New 4(1H)-Pyridinone Derivatives as Analgesic Agents

Aytemir, M. D., Uzbay, T. I., & EROL, D. D. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300409 · Cited by 15 · see citing works

Syntheses of N-Substituted-3-glucosyloxy-2-methyl-4-pyridones and Their Aglycones

Yasue, M., KAWAMURA, N., & Sakakibara, J. (1970) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.90.10_1222 · Cited by 15 · see citing works

Effect of desferrioxamine and hydroxypyridones on hemopoietic progenitors and neuroectodermal tumor cells

Timeus, F. S., Valle, P., Crescenzio, N., Ruggieri, L., Rosso, P., Pagliardi, G. L., di Montezemolo, L. C., Gabutti, V., & Ramenghi, U. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470307 · Cited by 11 · see citing works

Substituent Effects on 6-Substituted 3-Hydroxy-1-methyl-4-pyridones

Imafuku, K., Takahashi, K., & Matsumura, H. (1979) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.52.111 · Cited by 10 · see citing works

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 881 · see citing works

Therapeutics of Alzheimer's disease: Past, present and future

Anand, R., Gill, K. D., & Mahdi, A. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 748 · see citing works

Misfolded proteins in Alzheimer's disease and type II diabetes

DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15112f · Cited by 359 · see citing works

The benzazole scaffold: a SWAT to combat Alzheimer's disease

Noël, S., Cadet, S., Gras, E., & Hureau, C. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60086f · Cited by 217 · see citing works

Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ₄₂Peptide

Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202 · see citing works

Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease

Hayne, D. J., Lim, S., & Donnelly, P. S. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00026a · Cited by 176 · see citing works

The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer’s Disease

Savelieff, M. G., DeToma, A. S., Derrick, J. S., & Lim, M. H. (2014) · Accounts of Chemical Research · doi:10.1021/ar500152x · Cited by 174 · see citing works

Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid β-Protein Fibrillation and Cytotoxicity

Xiong, N., Dong, X., Zheng, J., Liu, F., & Sun, Y. P. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00915 · Cited by 158 · see citing works

The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151 · see citing works

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 146 · see citing works

Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

Rana, M., & Sharma, A. (2019) · Metallomics · doi:10.1039/c8mt00203g · Cited by 80 · see citing works

Werner coordination chemistry and neurodegeneration

Telpoukhovskaia, M. A., & Orvig, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35236b · Cited by 112 · see citing works

8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation

Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 92 · see citing works

Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation

Wang, X., Wang, X., Zhang, C., Jiao, Y., & Guo, Z. (2012) · Chemical Science · doi:10.1039/c2sc01100j · Cited by 87 · see citing works

Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer’s Disease Treatment

Han, X., & He, G. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00477 · Cited by 77 · see citing works

Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs

Oliveri, V., Giuffrida, M. L., Vecchio, G., Aiello, C., & Viale, M. (2012) · Dalton Transactions · doi:10.1039/c2dt12371a · Cited by 67 · see citing works

Neurodegenerative diseases – Understanding their molecular bases and progress in the development of potential treatments

Rowińska‐Żyrek, M., Salerno, M., & Kozłowski, H. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.03.026 · Cited by 64 · see citing works

Illicium Sesquiterpenes: Divergent Synthetic Strategy and Neurotrophic Activity Studies

Trzoss, L., Xu, J., Lacoske, M. H., Mobley, W. C., & Theodorakis, E. A. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300198 · Cited by 62 · see citing works

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease

Sheng, R., Tang, L., Jiang, L., Hong, L., Shi, Y., Zhou, N., & Hu, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00224 · Cited by 61 · see citing works

Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation.

Jones, M. R., Service, E., Thompson, J. R., Wang, M. C. P., Kimsey, I. J., DeToma, A. S., Ramamoorthy, A., Lim, M., & Storr, T. (2012) · Metallomics · doi:10.1039/c2mt20113e · Cited by 53 · see citing works

Copper Chelators: Chemical Properties and Bio-medical Applications

Tegoni, M., Valensin, D., Toso, L., & Remelli, M. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140601161939 · Cited by 56 · see citing works

Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities

Jiang, X., Zhou, T., Bai, R., & Xie, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01480 · Cited by 54 · see citing works

Multifunctional iron-chelators with protective roles against neurodegenerative diseases

Nunes, A. C. C., Marques, S. M., Quintanova, C., Silva, D. F., Cardoso, S. M., Chaves, S., & Santos, M. A. (2013) · Dalton Transactions · doi:10.1039/c3dt50406a · Cited by 51 · see citing works

A resorcinarene for inhibition of Aβ fibrillation

Han, X., Park, J., Wu, W., Malagón, A., Wang, L., Vargas, É. F., Wikramanayake, A. H., Houk, K. N., & Leblanc, R. M. (2016) · Chemical Science · doi:10.1039/c6sc04854d · Cited by 51 · see citing works

Clawing back: broadening the notion of metal chelators in medicine

Franz, K. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.12.021 · Cited by 50 · see citing works

Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity

Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2014) · Inorganic Chemistry · doi:10.1021/ic500926c · Cited by 48 · see citing works

Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer´s disease therapy

Hiremathad, A., Chand, K., Tolayan, L., Rajeshwari, R., Keri, R. S., Esteves, A. R., Cardoso, S. M., Chaves, S., & Santos, M. A. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.11.015 · Cited by 44 · see citing works

Multiple Function Fluorescein Probe Performs Metal Chelation, Disaggregation, and Modulation of Aggregated Aβ and Aβ-Cu Complex

Balakrishnan, M., Layek, S., Balaji, S., Trivedi, V., & Iyer, P. K. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00205 · Cited by 42 · see citing works

Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

Gucký, A., & Hamuľaková, S. (2024) · CNS Drugs · doi:10.1007/s40263-024-01093-0 · Cited by 39 · see citing works

Discovery of N -Aryl-pyridine-4-ones as Novel Potential Agrochemical Fungicides and Bactericides

Yu, X., Zhu, X., Zhou, Y., Li, Q., Hu, Z., Li, T., Tao, J., Dou, M., Zhang, M., Shao, Y., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06296 · Cited by 39 · see citing works

Tools of the Trade: Investigations into Design Strategies of Small Molecules to Target Components in Alzheimer's Disease

Derrick, J. S., & Lim, M. H. (2015) · ChemBioChem · doi:10.1002/cbic.201402718 · Cited by 38 · see citing works

Prochelator strategies for site-selective activation of metal chelators

Oliveri, V., & Vecchio, G. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.05.012 · Cited by 38 · see citing works

Multitarget trehalose-carnosine conjugates inhibit Aβ aggregation, tune copper(II) activity and decrease acrolein toxicity

Grasso, G. I., Bellia, F., Arena, G., Satriano, C., Vecchio, G., & Rizzarelli, E. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.060 · Cited by 35 · see citing works

Withanolide A: synthesis and structural requirements for neurite outgrowth

Liffert, R., Hoecker, J., Jana, C. K., Woods, T. M., Burch, P., Jessen, H. J., Neuburger, M. A., & Gademann, K. (2013) · Chemical Science · doi:10.1039/c3sc50653c · Cited by 34 · see citing works

Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators

Akam, E. A., Chang, T. M., Astashkin, A. V., & Tomat, E. (2014) · Metallomics · doi:10.1039/c4mt00153b · Cited by 32 · see citing works

Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study

Khodaverdian, V., Tapadar, S., MacDonald, I. A., Xu, Y., Ho, P.-Y., Bridges, A. E., Rajpurohit, P., Sanghani, B. A., Fan, Y., Thangaraju, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39214-1 · Cited by 31 · see citing works

Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species

He, X., Park, H. M., Hyung, S., DeToma, A. S., Kim, C., Ruotolo, B. T., & Lim, M. H. (2012) · Dalton Transactions · doi:10.1039/c2dt12207c · Cited by 31 · see citing works

3-Hydroxypyridinone Derivatives as Metal-Sequestering Agents for Therapeutic Use

Santos, M. A., & Chaves, S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.162 · Cited by 29 · see citing works

Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models

Rodríguez‐Rodríguez, C., Telpoukhovskaia, M. A., Alí‐Torres, J., Rodrı́guez-Santiago, L., Manso, Y., Bailey, G. A., Hidalgo, J., Sodupe, M., & Orvig, C. (2014) · Metallomics · doi:10.1039/c4mt00167b · Cited by 29 · see citing works

Tau-peptide fragments and their copper(II) complexes: Effects on Amyloid-β aggregation

Natale, G. D., Bellia, F., Sciacca, M. F. M., Campagna, T., & Pappalardo, G. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.09.061 · Cited by 25 · see citing works

3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents

Telpoukhovskaia, M. A., Rodríguez‐Rodríguez, C., Cawthray, J. F., Scott, L. E., Page, B. D. G., Alí‐Torres, J., Sodupe, M., Bailey, G. A., Patrick, B. O., & Orvig, C. (2013) · Metallomics · doi:10.1039/c3mt00135k · Cited by 23 · see citing works

Ionophoric polyphenols selectively bind Cu2+, display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila

Martínez, A., Alcendor, R. R., Rahman, T., Magdalena, P., Ismaila, S., & McCurdy, R. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.012 · Cited by 21 · see citing works

Mannosylated N ‐Aryl Substituted 3‐Hydroxypyridine‐4‐Ones: Synthesis, Hemagglutination Inhibitory Properties, and Molecular Modeling

Car, Ž., Hrenar, T., Peroković, V. P., Ribić, R., Seničar, M., & Tomić, S. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12329 · Cited by 18 · see citing works

Distinctive EPR signals provide an understanding of the affinity of bis-(3-hydroxy-4-pyridinonato) copper( ii ) complexes for hydrophobic environments

Rangel, M., Leite, A., Silva, A. M. N., Moniz, T., Nunes, A., Amorim, M., Queirós, C., Cunha-Silva, L., Gameiro, P., & Burgess, J. R. (2014) · Dalton Transactions · doi:10.1039/c4dt00642a · Cited by 18 · see citing works

Characterization of pyridinylimine and pyridinylmethylamine derivatives and their corresponding metal complexes

Braymer, J. J., Merrill, N. M., & Lim, M. H. (2011) · Inorganica Chimica Acta · doi:10.1016/j.ica.2011.08.056 · Cited by 16 · see citing works

3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability

Telpoukhovskaia, M. A., Cawthray, J. F., Rodríguez‐Rodríguez, C., Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.059 · Cited by 15 · see citing works

Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy

Jiang, L., Zhang, M., Tang, L., Weng, Q., Shen, Y., Hu, Y., & Sheng, R. (2016) · RSC Advances · doi:10.1039/c5ra25788c · Cited by 15 · see citing works

Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones

Telpoukhovskaia, M. A., Rodríguez‐Rodríguez, C., Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.12.003 · Cited by 13 · see citing works

A Glycosylated Prodrug to Attenuate Neuroinflammation and Improve Cognitive Deficits in Alzheimer’s Disease Transgenic Mice

Kim, M., Park, M., Nam, G., Lee, M., Kang, J., Song, I., Choi, M., Jin, H. K., Bae, J., & Lim, M. H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00677 · Cited by 10 · see citing works

Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes

Turnaturi, R., Oliveri, V., Viale, M., Monticone, M., & Vecchio, G. (2015) · ChemPlusChem · doi:10.1002/cplu.201500289 · Cited by 10 · see citing works

Synthesis of the tetracyclic core of Illicium sesquiterpenes using an organocatalyzed asymmetric Robinson annulation

Trzoss, L., Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.126 · Cited by 10 · see citing works

Methylenediphosphonotetrathioate: Synthesis, Characterization, and Chemical Properties

Amir, A., Sayer, A. H., Ezra, A., & Fischer, B. (2013) · Inorganic Chemistry · doi:10.1021/ic3026057 · Cited by 8 · see citing works

Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases

Beck, M. W., Pithadia, A. S., DeToma, A. S., Korshavn, K. J., & Lim, M. H. (2014) · Wiley eBooks · doi:10.1002/9781118697191.ch10 · Cited by 8 · see citing works

Copper and zinc complexes of kojic acid and related ligands

Bhatia, P. H., Kociok-Köhn, G. I., & Molloy, K. C. (2015) · Transition Metal Chemistry · doi:10.1007/s11243-015-9935-0 · Cited by 5 · see citing works

Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal‐Induced β‐Amyloid Aggregates

Yadav, R., Murthy, R. V., & Kikkeri, R. V. (2015) · ChemBioChem · doi:10.1002/cbic.201500162 · Cited by 5 · see citing works

Metal Ion Imbalance in the Body

Dabrowiak, J. C. (2017) · Wiley eBooks · doi:10.1002/9781119191377.ch8 · Cited by 5 · see citing works

Recent advances in therapeutical applications of the versatile hydroxypyridinone chelators

Sharma, S., Baral, M., & Kanungo, B. K. (2022) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-021-01114-1 · Cited by 4 · see citing works

Synthesis, Crystal and Molecular Structure of Novel Adamantyl Derivatives of N-Aryl Substituted 3-Hydroxy-2-methylpyridine-4-ones

Peroković, V. P., Prugovečki, B., & Car, Ž. (2013) · Croatica Chemica Acta · doi:10.5562/cca2339 · Cited by 4 · see citing works

Pyridinones Are Not Antioxidants As Shown by Kinetics of Free Radical Autoxidation, but They Prevent Radical Oxidations Catalyzed by Toxic Heavy Metals

Ramsaywack, S., Vogels, C. M., Ricker, S. L., Westcott, S. A., & Barclay, L. R. C. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300486r · Cited by 4 · see citing works

Nanoparticles as Artificial Chaperons Suppressing Protein Aggregation: Remedy in Neurodegenerative Diseases

Tripathi, S., Pathak, S., & Kale, A. (2021) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-61985-5_12 · Cited by 3 · see citing works

Copper, zinc and tin 3-hydroxypyridinones

Barret, M. C., Bhatia, P. H., Kociok-Köhn, G. I., & Molloy, K. C. (2015) · Transition Metal Chemistry · doi:10.1007/s11243-015-9912-7 · Cited by 3 · see citing works

Neuritogenic Surfaces using Natural Product Analogs

Burch, P., Schmid, F., & Gademann, K. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300671 · Cited by 3 · see citing works

Developing Ligands to Target Transition Metals in Cancer

Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3 · see citing works

Azole derivatives as novel non-iron-chelating inhibitors of prolyl hydroxylase 3 for HIF-1 activation

Cao, J., Ma, X., Wang, X., Wang, X., Zhang, Z., Geng, Z., & Wang, Z. (2013) · MedChemComm · doi:10.1039/c3md00117b · Cited by 2 · see citing works

Comparison of Inhibitory Activities of meta and para Substituted N-aryl 3-Hydroxypyridin-4-one Mannosides Towards Type 1 Fimbriated E. coli

Peroković, V. P., Ribić, R., Car, Ž., & Tomić, S. (2016) · Croatica Chemica Acta · doi:10.5562/cca2890 · Cited by 2 · see citing works

3-Hidroksipiridin-4-oni (II. dio): Biološka primjena kao kelatora željeza

Zavod za organsku kemiju, K. O., Car, Ž., Peroković, V. P., Zavod za organsku kemiju, K. O., Tomić, S., & Zavod za organsku kemiju, K. O. (2017) · Kemija u industriji · doi:10.15255/kui.2015.051 · Cited by 2 · see citing works

An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases

Lewis, F. W., & Tétard, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00020-8 · Cited by 1 · see citing works

3-Hidroksipiridin-4-oni (I. dio): Priprava i kelirajući učinak

Zavod za organsku kemiju, K. O., Car, Ž., Peroković, V. P., Zavod za organsku kemiju, K. O., Tomić, S., & Zavod za organsku kemiju, K. O. (2016) · Kemija u industriji · doi:10.15255/kui.2015.050

BindingDB Entry 50012329: Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.

BindingDB (2022) · UC San Diego · doi:10.7270/q28p646m

Multifunctional pro-ligands as potential Alzheimer’s disease therapeutics

Scott, L. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0061398

3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents

Telpoukhovskaia, M. A., Rodríguez‐Rodríguez, C., Cawthray, J. F., Scott, L. E., Page, B. D. G., Alí‐Torres, J., Sodupe, M., Bailey, G. A., Patrick, B. O., & Orvig, C. (2013) · Metallomics · doi:10.1039/c3mt00135k · Cited by 23 · see citing works

Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2008) · Dalton Transactions · doi:10.1039/b815404j · Cited by 38 · see citing works

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease

Sheng, R., Tang, L., Jiang, L., Hong, L., Shi, Y., Zhou, N., & Hu, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00224 · Cited by 61 · see citing works

In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease

Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Merkel, M., Böhmerle, K., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2009) · Dalton Transactions · doi:10.1039/b918439b · Cited by 56 · see citing works